technetium-tc-99m-tetrofosmin and gallium-citrate

technetium-tc-99m-tetrofosmin has been researched along with gallium-citrate* in 2 studies

Trials

1 trial(s) available for technetium-tc-99m-tetrofosmin and gallium-citrate

ArticleYear
Comparison of gallium-67 citrate and technetium-99m tetrofosmin scan to detect Hodgkin's disease.
    Annals of nuclear medicine, 2003, Volume: 17, Issue:6

    The purpose of this study was to compare the usefulness of gallium-67 citrate (67Ga) and technetium-99m tetrofosmin (Tc-TF) scan to detect Hodgkin's disease (HD).. In this study, 24 patients with HD underwent 67Ga and Tc-TF scan before receiving any therapy.. 67Ga scan could detect HD in all 24 (100%) patients. Tc-TF scan could detect HD in 22/24 (91.6%) patients, but it was false-negative in one case of infradiaphragmatic HD and in another case with chemotherapy resistance. There was no significant difference in detection sensitivity between 67Ga and Tc-TF scan.. We conclude that Tc-TF scan can not replace conventional 67Ga scan to detect HD.

    Topics: Adult; Age Factors; Citrates; False Negative Reactions; Female; Gallium; Hodgkin Disease; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Whole-Body Counting

2003

Other Studies

1 other study(ies) available for technetium-tc-99m-tetrofosmin and gallium-citrate

ArticleYear
Usefulness of 99mTc-tetrofosmin scintigraphy in different variants of Kaposi's sarcoma.
    Oncology, 2003, Volume: 65, Issue:4

    We investigated (99m)Tc-tetrofosmin scintigraphy in 27 patients with Kaposi's sarcoma: 20 had classic (CK), 5 AIDS-associated (AK) and 2 transplantation-associated (TK) variants. Twenty-three patients had clinically evident cutaneous and/or mucosal lesions, 9 of them with associated sarcomatous lymphadenopathy; 2 TK patients had only lymph nodes or other extracutaneous Kaposi sites. Both planar and SPECT (99m)Tc-tetrofosmin scintigraphies were performed in all cases and neck pinhole (P)-SPECT in selected patients. (99m)Tc-tetrofosmin uptake was observed in 88% of patients with clinically evident cutaneous and/or extracutaneous Kaposi lesions. Scintigraphy gave additional information on cutaneous lesion extent, particularly SPECT regarding deep invasion and subclinical sites in some cases. However, scintigraphy was less sensitive in the detection of small, isolated and scattered lesions. SPECT/P-SPECT were positive in 8/8 patients with sarcomatous lymph nodes, planar imaging in 5/8, ultrasonography in 7/8, while all procedures were negative in 6 other patients with reactive or HIV infection lymph nodes. SPECT demonstrated lymphadenopathy remission in 1 TK patient after immunosuppressive therapy modification and, like planar imaging, ascertained an associated lymphoma with (67)Ga-citrate combined. (99m)Tc-tetrofosmin scintigraphy, especially SPECT, can be useful both in the detection and staging of Kaposi sarcoma lesions as a complementary tool to clinical and other conventional diagnostic methods.

    Topics: Aged; Aged, 80 and over; Citrates; Duodenal Neoplasms; Female; Gallium; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma, Kaposi; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed, Single-Photon; Tonsillar Neoplasms

2003